Literature DB >> 8751293

Long-term complications of hydrocephalus.

S Sgouros1, C Malluci, A R Walsh, A D Hockley.   

Abstract

Problems may still occur for patients treated for infantile hydrocephalus who graduate to become adults, including unsatisfactory follow-up. We have continued the supervision in an adult institution of 70 children originally treated in the Birmingham Children's Hospital between 1974 and 1978. In these patients, 33 (16.4%) of a total of 201 shunt revision procedures and 5 of the 8 subtemporal decompressions for slit ventricle syndrome were performed after the age of 16 years. Similarly, 7 shunt infections occurred in this age group. Two patients died from a blocked shunt. Other late complications included blindness (n = 1), endocarditis (n = 1), and renal and heart failure requiring consideration of organ transplantation (n = 1). Also 2 patients developed clinical features of arachnoiditis following earlier lumboperitoneal shunting. An overall good long-term outcome was observed. The majority of children graduated from a normal school (63%) or a school for physically handicapped children (21%). 67% of the patients are socially independent, but live at home with their parents. A further 16% have left their parents' home and live either on their own (10%) or with their partners (6%). It is clear that although a good social and educational outcome is expected, significant clinical problems do arise during adulthood for patients shunted in infancy, even after a long period of apparent stability. Regular follow-up by surgeons familiar with these problems is essential.

Entities:  

Mesh:

Year:  1995        PMID: 8751293     DOI: 10.1159/000120949

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  17 in total

1.  Hydrocephalus--what's new?

Authors:  P Chumas; A Tyagi; J Livingston
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

Review 2.  The role of different imaging modalities: is MRI a conditio sine qua non for ETV?

Authors:  Erik J van Lindert; Tjemme Beems; J André Grotenhuis
Journal:  Childs Nerv Syst       Date:  2006-08-30       Impact factor: 1.475

Review 3.  Shunt Devices for Neurointensivists: Complications and Management.

Authors:  G Smith; J Pace; A Scoco; G Singh; K Kandregula; S Manjila; C Ramos-Estebanez
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

Review 4.  Cerebrospinal Fluid Shunting Complications in Children.

Authors:  Brian W Hanak; Robert H Bonow; Carolyn A Harris; Samuel R Browd
Journal:  Pediatr Neurosurg       Date:  2017-03-02       Impact factor: 1.162

Review 5.  Neuroimaging of ventriculoperitoneal shunt complications in children.

Authors:  Ahilan Sivaganesan; Rajesh Krishnamurthy; Deshdeepak Sahni; Chitra Viswanathan
Journal:  Pediatr Radiol       Date:  2012-06-28

6.  Ventriculoperitoneal shunt malfunction caused by fractures and disconnections over 10 years of follow-up.

Authors:  Fatih Serhat Erol; Sait Ozturk; Bekir Akgun; Metin Kaplan
Journal:  Childs Nerv Syst       Date:  2017-01-17       Impact factor: 1.475

7.  Very long-term follow-up of adults treated in infancy for hydrocephalus.

Authors:  Eva-Karin Persson; Barbro Lindquist; Paul Uvebrant; Elisabeth Fernell
Journal:  Childs Nerv Syst       Date:  2011-06-24       Impact factor: 1.475

Review 8.  Infantile posthemorrhagic hydrocephalus.

Authors:  Vasilios Tsitouras; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

9.  Influence of the shunt type in the difference in reduction of volume between the two lateral ventricles in shunted hydrocephalic children.

Authors:  Harsh Jain; Kal Natarajan; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

Review 10.  Antibiotic prophylaxis for shunt surgery of children: a systematic review.

Authors:  H Xu; F Hu; H Hu; W Sun; W Jiao; R Li; T Lei
Journal:  Childs Nerv Syst       Date:  2015-10-23       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.